Financial insights of AMED

MyFinsight

For the quarter ending 2025-06-30, AMED made $54,741K in revenue. $28,084K in net income. Net profit margin of 51.30%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-06-30	2025-03-31	2024-09-30	2024-06-30
Other	-	57,965	56,777	58,602
Salaries and benefits	-	131,968	134,833	129,323
Depreciation and amortization	-	4,447	4,774	4,386
Interest expense	-	-	-	7,895
Miscellaneous, net	4,506	1,508	2,522	1,779
Cost of service, inclusive of depreciation	-	334,050	337,563	326,933
Interest income	3,016	2,873	2,017	1,617
Non-cash compensation	-	6,223	6,726	7,828
Merger termination fee	-	-	-	0
Interest expense	6,415	6,422	7,772	-
Merger-related expenses	-	16,769	16,669	11,901
Equity in earnings from equity method investments	1,641	1,794	1,891	1,515
Total operating expenses	-	551,422	557,342	538,973
Gain on equity method investment	0	48,093	-	-
Other Operating Income (Expense), Net	-	-	-	0
Revenues	-	594,781	587,671	591,187
Total other income (expense), net	2,748	47,846	-1,342	-2,984
Operating income	45,578	43,359	30,329	52,214
Income before income taxes	48,326	91,205	28,987	49,230
Income tax expense	19,274	29,384	12,473	16,657
Net income	29,052	61,821	16,514	32,573
Net income attributable to noncontrolling interests	968	809	-397	272
Net income attributable to amedisys, inc	28,084	61,012	16,911	32,301

Net income attributable to amedisys, inc. common stockholders	0.84	1.84	0.51	0.98
Net income attributable to amedisys, inc. common stockholders	0.85	1.86	0.52	0.99
Weighted average shares outstanding, basic (shares)	32,849,000	32,793,000	32,745,000	32,706,000
Weighted average shares outstanding, diluted (shares)	33,289,000	33,218,000	33,135,000	33,047,000